| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 203.66B | 197.00B | 174.90B | 178.33B | 156.29B | 214.99B |
| Gross Profit | 26.67B | 25.69B | 22.92B | 25.08B | 25.77B | 18.57B |
| EBITDA | 13.16B | 13.29B | 9.71B | 14.00B | 15.82B | 9.54B |
| Net Income | 4.78B | 4.80B | 1.60B | 5.49B | 7.51B | 2.86B |
Balance Sheet | ||||||
| Total Assets | 195.82B | 196.63B | 182.89B | 191.89B | 176.44B | 147.92B |
| Cash, Cash Equivalents and Short-Term Investments | 20.77B | 18.76B | 21.47B | 26.99B | 26.69B | 27.05B |
| Total Debt | 54.27B | 53.74B | 55.20B | 71.82B | 61.80B | 59.12B |
| Total Liabilities | 127.18B | 126.32B | 116.54B | 128.84B | 119.11B | 104.55B |
| Stockholders Equity | 68.06B | 69.70B | 65.75B | 62.52B | 56.87B | 42.85B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 463.00M | 11.77B | -4.56B | -7.59B | 1.04B |
| Operating Cash Flow | 0.00 | 7.00B | 15.21B | 226.00M | -3.33B | 4.10B |
| Investing Cash Flow | 0.00 | -4.71B | -2.62B | -7.04B | -3.26B | -2.47B |
| Financing Cash Flow | 0.00 | -4.80B | -19.28B | 5.90B | 5.76B | 2.85B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥207.75B | 13.34 | 11.58% | 1.62% | 9.81% | 30.20% | |
68 Neutral | ¥94.38B | 15.19 | ― | 2.98% | 8.89% | 102.20% | |
68 Neutral | ¥2.97T | 30.81 | 1.33% | 1.98% | 3.15% | -63.65% | |
66 Neutral | ¥710.32B | 33.38 | 2.14% | 2.83% | -0.64% | -65.65% | |
64 Neutral | ¥630.13B | 28.79 | 5.02% | 2.12% | -7.98% | -42.51% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
55 Neutral | ¥56.17B | 58.69 | ― | 9.18% | -35.81% | -138.00% |
Alconix Corporation reported solid growth for the nine months ended Dec. 31, 2025, with net sales rising 7.5% year on year to ¥157.8 billion and profit attributable to owners of parent climbing 38.4% to ¥4.9 billion, reflecting strong operating leverage. The equity ratio remained broadly stable despite an increase in total assets, while earnings per share advanced to ¥164.90 as the company modestly reduced treasury shares and benefited from higher profitability.
The company kept its full-year forecast unchanged, projecting net sales of ¥215 billion and a 12.4% rise in full-year profit to ¥5.4 billion, and maintained its plan to lift the annual dividend to ¥84 per share. Alconix also expanded its consolidation scope by adding Nano Seeds Corporation, signaling ongoing portfolio development as it balances growth investments with higher shareholder returns in a supportive earnings environment.
The most recent analyst rating on (JP:3036) stock is a Buy with a Yen3126.00 price target. To see the full list of analyst forecasts on ALCONIX Corporation stock, see the JP:3036 Stock Forecast page.